Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

725

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Carcinoma, Ductal, Breast
Receptors, Estrogen (for ER-positive Requirement)

Interventions

DEVICE: ctDNA-Guided Treatment Strategy

Sponsor

Natera, Inc.